Captor Therapeutics S.A. (CTX) — Capital Reinvestment Ratio
Captor Therapeutics S.A. (CTX) has a Capital Reinvestment Ratio of 0.00x as of March 2025, meaning it reinvests 0% of its operating cash flow (zł23.06 Million) in capital expenditures (zł83.00K). Check CTX tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Captor Therapeutics S.A. Capital Reinvestment Ratio (2019–2019)
This chart tracks Captor Therapeutics S.A.'s Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Captor Therapeutics S.A. (CTX) cash flow conversion.
Annual Capital Reinvestment Ratio for Captor Therapeutics S.A. (2019–2019)
Year-by-year Capital Reinvestment Ratio for Captor Therapeutics S.A. from 2019 to 2019. See Captor Therapeutics S.A. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (PLN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.05x | zł4.39 Million | zł229.00K | — |